Company
FILANA THERAPEUTICS, INC.
FLNA · CIK 0001069530
Purchase of 100,000 shares at $0.92 per share.
Reporting Person Barry Richard · Officer Title President & CEO · Transaction Code P
Traded Sep 30, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001437749-26-031654 · filed 2026-10-01 · View filing →
Purchase of 206,813 shares at $0.90 per share.
Reporting Person Barry Richard · Officer Title President & CEO · Transaction Code P
Traded Sep 29, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001437749-26-031654 · filed 2026-10-01 · View filing →
Purchase of 93,091 shares at $0.84 per share.
Reporting Person Barry Richard · Officer Title President & CEO · Transaction Code P
Traded Sep 28, 2026 · Disclosed Sep 30, 2026
Source: SEC Form 4 · 0001437749-26-031597 · filed 2026-09-30 · View filing →